Pharmacological inhibition of Bcl-2 family members reactivates TRAIL-induced apoptosis in malignant glioma

作者: Holger Hetschko , Valerie Voss , Sigrid Horn , Volker Seifert , Jochen H. M. Prehn

DOI: 10.1007/S11060-007-9472-6

关键词:

摘要: The major aim of this study was to develop novel therapeutic approaches potentiate and reactivate apoptosis induced by TNF-Related Apoptosis Inducing Ligand (TRAIL) in malignant glioma. Analysis five glioma cell lines (U87, U251, U373, MZ-54 MZ-18) indicated that only two the were sensitive TRAIL alone. resistance not correlated expression levels death receptors DR4 DR5 or decoy DcR1 DcR2, suggesting it mediated inactivation TRAIL-induced downstream signalling. Activation BH3 protein Bid subsequent activation mitochondrial pathway are known play a pivotal role apoptosis. Since process is blocked overexpression anti-apoptotic Bcl-2 family members, we analyzed potential mimetics potentiating Treatment with combination specific inhibitor HA14-1 Bcl-2/Bcl-xL BH3I-2′ potently enhanced TRAIL-sensitive U87 cells dose-dependent fashion. significantly reactivated one (U343) (MZ-54 three investigated TRAIL-insensitive lines, respectively. Knockdown member Mcl-1 RNA interference had no additional effect on U343 cells. Our data indicate Bcl-xL fundamental roles suggest using agonistic receptor antibodies may represent promising approach therapy-resistant high grade gliomas.

参考文章(26)
Stéphane Martin, Claire Toquet, Lisa Oliver, Pierre-François Cartron, Pascale Perrin, Khaled Meflah, Paulette Cuillère, François M. Vallette, Expression of bcl-2, bax and bcl-xl in human gliomas: a re-appraisal. Journal of Neuro-oncology. ,vol. 52, pp. 129- 139 ,(2001) , 10.1023/A:1010689121904
Paul Kleihues, David N. Louis, Bernd W. Scheithauer, Lucy B. Rorke, Guido Reifenberger, Peter C. Burger, Webster K. Cavenee, The WHO Classification of Tumors of the Nervous System Journal of Neuropathology and Experimental Neurology. ,vol. 61, pp. 215- 225 ,(2002) , 10.1093/JNEN/61.3.215
Francesco Beguinot, Gerolama Condorelli, Kenneth C. Petruk, Wilson H. Roa, Alessandra Trencia, Erwin G. Van Meir, V. Wee Yong, Chunhai Hao, Ian F. Parney, Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. Cancer Research. ,vol. 61, pp. 1162- 1170 ,(2001)
Guido Kroemer, Lorenzo Galluzzi, Catherine Brenner, Mitochondrial Membrane Permeabilization in Cell Death Physiological Reviews. ,vol. 87, pp. 99- 163 ,(2007) , 10.1152/PHYSREV.00013.2006
Suzanne Cory, Jerry M. Adams, Killing cancer cells by flipping the Bcl-2/Bax switch Cancer Cell. ,vol. 8, pp. 5- 6 ,(2005) , 10.1016/J.CCR.2005.06.012
O Bogler, Michael Weller, Apoptosis in gliomas and its role in their current and future treatment Frontiers in Bioscience. ,vol. 7, pp. e339- 353 ,(2002) , 10.2741/A928
Jin H. Song, Doyoun K. Song, Beata Pyrzynska, Kenneth C. Petruk, Erwin G. Meir, Chunhai Hao, TRAIL Triggers Apoptosis in Human Malignant Glioma Cells Through Extrinsic and Intrinsic Pathways Brain Pathology. ,vol. 13, pp. 539- 553 ,(2006) , 10.1111/J.1750-3639.2003.TB00484.X
S. Bouralexis, D. M. Findlay, A. Evdokiou, Death to the bad guys: targeting cancer via Apo2L/TRAIL. Apoptosis. ,vol. 10, pp. 35- 51 ,(2005) , 10.1007/S10495-005-6060-0
Mark F. van Delft, Andrew H. Wei, Kylie D. Mason, Cassandra J. Vandenberg, Lin Chen, Peter E. Czabotar, Simon N. Willis, Clare L. Scott, Catherine L. Day, Suzanne Cory, Jerry M. Adams, Andrew W. Roberts, David C.S. Huang, The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell. ,vol. 10, pp. 389- 399 ,(2006) , 10.1016/J.CCR.2006.08.027